Search research articles
Contact Us
Filters
Showing results (21-30 of 146) with videos related to
Page
of 15
Sort By:
Journal of Experimental Therapeutics & Oncology
|
June 8, 2007
Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer
Gaynor Davies, Richard J Ablin, Malcolm D Mason, et al.
BJU International
|
July 2, 2011
Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma
Michael D Shelley, Anne Cleves, Timothy J Wilt, et al.
Oncology Reports
|
August 4, 2012
The influence of matriptase-2 on prostate cancer in vitro: a possible role for β-catenin
Siobhan L Webb, Andrew J Sanders, Malcolm D Mason, et al.
Journal of Medicinal Chemistry
|
January 20, 2006
Novel potential anticancer naphthyl phosphoramidates of BVdU: separation of diastereoisomers and assignment of the absolute configuration of the phosphorus center
Costantino Congiatu, Andrea Brancale, Malcolm D Mason, et al.
Microvascular Research
|
November 6, 2008
The prostate transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway
Wen G Jiang, Richard J Ablin, Howard G Kynaston, et al.
European Urology
|
July 8, 2008
Does the extent of carcinoma in prostatic biopsies predict prostate-specific antigen recurrence? A systematic review
Patricia Harnden, Michael D Shelley, Brian Naylor, et al.
Journal of Translational Medicine
|
April 29, 2011
Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer
Richard J Ablin, Howard G Kynaston, Malcolm D Mason, et al.
Anticancer Research
|
July 26, 2017
Potential Implication of Paxillin in Cancer Establishment Within the Bone Environment
Anna D Sobkowicz, Andrew J Sanders, Malcolm D Mason, et al.
Cancer Research
|
August 3, 2007
Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2
Aled Clayton, J Paul Mitchell, Jacquelyn Court, et al.
International Journal of Molecular Medicine
|
November 8, 2006
Does the PGC-1/PPARgamma pathway play a role in Com-1/p8 mediated cell growth inhibition in prostate cancer?
Wen G Jiang, Gaynor Davies, Howard Kynaston, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 146) with videos related to
Sort By:
Page
of 15
Journal of Experimental Therapeutics & Oncology
|
June 8, 2007
Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer
Gaynor Davies, Richard J Ablin, Malcolm D Mason, et al.
BJU International
|
July 2, 2011
Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma
Michael D Shelley, Anne Cleves, Timothy J Wilt, et al.
Oncology Reports
|
August 4, 2012
The influence of matriptase-2 on prostate cancer in vitro: a possible role for β-catenin
Siobhan L Webb, Andrew J Sanders, Malcolm D Mason, et al.
Journal of Medicinal Chemistry
|
January 20, 2006
Novel potential anticancer naphthyl phosphoramidates of BVdU: separation of diastereoisomers and assignment of the absolute configuration of the phosphorus center
Costantino Congiatu, Andrea Brancale, Malcolm D Mason, et al.
Microvascular Research
|
November 6, 2008
The prostate transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway
Wen G Jiang, Richard J Ablin, Howard G Kynaston, et al.
European Urology
|
July 8, 2008
Does the extent of carcinoma in prostatic biopsies predict prostate-specific antigen recurrence? A systematic review
Patricia Harnden, Michael D Shelley, Brian Naylor, et al.
Journal of Translational Medicine
|
April 29, 2011
Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer
Richard J Ablin, Howard G Kynaston, Malcolm D Mason, et al.
Anticancer Research
|
July 26, 2017
Potential Implication of Paxillin in Cancer Establishment Within the Bone Environment
Anna D Sobkowicz, Andrew J Sanders, Malcolm D Mason, et al.
Cancer Research
|
August 3, 2007
Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2
Aled Clayton, J Paul Mitchell, Jacquelyn Court, et al.
International Journal of Molecular Medicine
|
November 8, 2006
Does the PGC-1/PPARgamma pathway play a role in Com-1/p8 mediated cell growth inhibition in prostate cancer?
Wen G Jiang, Gaynor Davies, Howard Kynaston, et al.
Page
of 15